Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
6869 On Other Exchanges
Symbol
Exchange
6869 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

sysmex corp (6869) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SYSMEX CORP (6869)

Related News

No related news articles were found.

sysmex corp (6869) Related Businessweek News

No Related Businessweek News Found

sysmex corp (6869) Details

Sysmex Corporation, together with its subsidiaries, engages in the research and development, production, sale, service, and support of diagnostic instruments, reagents, and software worldwide. The company provides diagnostics products for use in the areas of hematology, hemostasis, immunochemistry, clinical chemistry, urinalysis, and others; and La-vietal LS, a clinical testing instrument system that links clinical testing instruments and other systems to provide an efficient operating environment. It also offers particle analyzer products, including FPIA-3000 Flow Particle Image Analyzer, which offers automated analysis of particle size and shape; FPIA-3000 Darkfield unit to analyze samples, such as drugs, mica, and biological cells; and XT-2000iV, an animal blood cell analysis software used in the hematological analysis of laboratory veterinary animals, such as rats, mice, or dogs. In addition, the company provides life sciences solutions comprising automated gene amplification detector, a system for the detection of lymph node metastasis based on the one-step nucleic acid amplification method used for the diagnosis of breast, colon, and stomach cancer lymph node diagnosis in hospitals and other facilities, as well as a laboratory testing service for research involving the risk of recurrence of breast cancer. Further, it offers ASTRIM FIT, a peripheral artery monitoring device that measures hemoglobin levels without blood sampling and is used in fitness centers and various other sites, as well as sells health management support software. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

5,903 Employees
Last Reported Date: 06/19/15
Founded in 1968

sysmex corp (6869) Top Compensated Officers

Chairman of the Managing Board, Chief Executi...
Total Annual Compensation: ¥250.0M
Compensation as of Fiscal Year 2015.

sysmex corp (6869) Key Developments

Sysmex Corp., Q1 2016 Pre Recorded Earnings Call, Aug 05, 2015

Sysmex Corp., Q1 2016 Pre Recorded Earnings Call, Aug 05, 2015

Sysmex Corp. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2015; Provides Earnings Guidance for the Six Months Ending September 30, 2015 and for the Full Year Ending March 31, 2016; Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal 2016

Sysmex Corp. announced consolidated earnings results for the first quarter ended June 30, 2015. For the period, the company reported net sales of JPY 57,641 million against JPY 46,737 million a year ago. Operating income was JPY 11,290 million against JPY 8,763 million a year ago. Ordinary income was JPY 11,293 million against JPY 8,507 million a year ago. Profit attributable to owners of parent was JPY 7,506 million or JPY 35.99 per diluted share against JPY 5,187 million or JPY 24.99 per diluted share a year ago. Income before income taxes and minority interest was JPY 12,317 million against JPY 8,501 million a year ago. Net cash provided by operating activities was JPY 2,358 million compared to JPY 3,763 million a year ago. Purchase of property, plant and equipment was JPY 3,554 million compared to JPY 2,235 million a year ago. Purchase of intangible assets was JPY 1,095 million compared to JPY 810 million a year ago. Net assets per share as on June 30, 2015 were JPY 830.08 against JPY 812.37 as on March 31, 2015. The company provided earnings guidance for the six months ending September 30, 2015 and for the full year ending March 31, 2016. For the six months ending September 30, 2015, the company expects net sales of JPY 115,000 million, operating income of JPY 24,000 million, ordinary income of JPY 24,000 million and profit attributable to owners of parent of JPY 15,500 million or JPY 74.66 per share. For the year ending March 31, 2016, the company expects net sales of JPY 245,000 million, operating income of JPY 50,000 million, ordinary income of JPY 50,000 and profit attributable to owners of parent of JPY 31,800 million or JPY 153.15 per share. For the second quarter of fiscal 2016, the company expects to pay a dividend of JPY 20 per share against JPY 16 per share a year ago. For the full year ending March 31, 2016, the company expects to pay a year end dividend of JPY 20 per share compared to the dividend of JPY 22 per share paid in the previous year. Annual dividend will be JPY 40 per share compared to the dividend of JPY 38 per share paid in the previous year.

Sysmex Corporation Expands Reagent Factory in Germany

Sysmex Corporation has expanded its reagent factory in Germany and reinforced its reagent production structure to meet expected increases in demand for reagents in EMEA (Europe, the Middle East and Africa). To provide a stable supply of reagents in response to expected increases in demand in EMEA, Sysmex has expanded its reagent factory in Germany, raising its capacity by around 50%. The extension features an optimized floor layout to enhance product quality and boost production efficiency. The factory is ecofriendly and includes environmental equipment to meet Germany's stringent environmental regulations, including an ice thermal storage system. This thermal storage air conditioning system uses natural energy, taking advantage of seasonal differences. Going forward, Sysmex plans to accelerate development of its production system to meet local market environments and growth to ensure a steady supply of products to customers throughout the world.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
6869:JP ¥7,050.00 JPY -140.00

6869 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alere Inc $51.89 USD +0.04
Bio-Rad Laboratories Inc $137.61 USD +0.59
BioMerieux €97.80 EUR -0.50
PerkinElmer Inc $47.95 USD +0.39
Shimadzu Corp ¥1,678 JPY -28.00
View Industry Companies
 

Industry Analysis

6869

Industry Average

Valuation 6869 Industry Range
Price/Earnings 51.8x
Price/Sales 6.4x
Price/Book 8.6x
Price/Cash Flow 46.0x
TEV/Sales 6.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SYSMEX CORP, please visit www.sysmex.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.